Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis

被引:0
|
作者
Talal Asif
Aviral Vij
Bartlomiej Radzik
Hudson Stern
Patricia Simples
Quraish Ghadiali
Saurabh Malhotra
机构
[1] University of Missouri,Division of Cardiology, Truman Medical Center
[2] Cook County Health,Division of Cardiology
[3] Rush Medical College,Division of Cardiology
[4] Cook County Health,Division of Pathology
[5] Cook County Health,Division of Ophthalmology
来源
关键词
Hereditary transthyretin cardiac amyloidosis; Pyrophosphate scintigraphy; Cardiac magnetic resonance;
D O I
暂无
中图分类号
学科分类号
摘要
We present a case of a patient with worsening visual acuity and dense vitreal debris who was found to have vitreal transthyretin amyloid (ATTR) infiltration. Cardiac workup, performed to identify systemic amyloidosis, demonstrated focal myocardial amyloid infiltration on pyrophosphate (PYP) scintigraphy and cardiac magnetic resonance (CMR), resulting in a diagnosis of subclinical ATTR cardiac amyloidosis (ATTR-CA). Patient was identified as a carrier of p.S70R mutation which results in an aggressive ATTR phenotype. Patient is tolerating transthyretin silencer therapy well. Through this case, we discuss the role of a multimodality imaging approach for the diagnosis of subclinical ATTR-CA.
引用
收藏
页码:792 / 799
页数:7
相关论文
共 50 条
  • [31] Cardiac involvement in hereditary-transthyretin related amyloidosis
    Rapezzi, Claudio
    Longhi, Simone
    Milandri, Agnese
    Lorenzini, Massimiliano
    Gagliardi, Christian
    Gallelli, Ilaria
    Leone, Ornella
    Quarta, Candida Cristina
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 : 16 - 21
  • [32] Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis
    Guo, Honghui
    Wu, Sha
    Xiang, Xin
    Wang, Shuai
    Fang, Zhihui
    Ye, Qianchun
    Zou, Yao
    Wang, Yunhua
    Peng, Daoquan
    Ma, Xiaowei
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (04) : 288 - 295
  • [33] Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis
    Honghui Guo
    Sha Wu
    Xin Xiang
    Shuai Wang
    Zhihui Fang
    Qianchun Ye
    Yao Zou
    Yunhua Wang
    Daoquan Peng
    Xiaowei Ma
    Annals of Nuclear Medicine, 2024, 38 : 288 - 295
  • [34] Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis
    Gisela D. Puig-Carrion
    Alex Reyentovich
    Stuart D. Katz
    Clinical Autonomic Research, 2019, 29 : 45 - 53
  • [35] FROM BOWEL ULTRASOUND TO A DIAGNOSIS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
    Toppeta, A.
    Dell'Era, A.
    Mantia, B.
    Molteni, P.
    Pellegrinelli, A.
    Marceca, A.
    Ardizzone, S.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S176 - S177
  • [36] Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
    Carroll, Antonia
    Dyck, P. James
    de Carvalho, Mamede
    Kennerson, Marina
    Reilly, Mary M.
    Kiernan, Matthew C.
    Vucic, Steve
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, : 668 - 678
  • [37] Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis
    Puig-Carrion, Gisela D.
    Reyentovich, Alex
    Katz, Stuart D.
    CLINICAL AUTONOMIC RESEARCH, 2019, 29 (Suppl 1) : 45 - 53
  • [38] Hereditary transthyretin amyloidosis
    Hund, E.
    NERVENARZT, 2014, 85 (10): : 1291 - 1297
  • [39] Are there predictor variables for the diagnosis of transthyretin cardiac amyloidosis?
    Goena, C.
    Arana, X.
    Villanueva, I.
    Solla, I.
    Rengel, A.
    Querejeta, R.
    EUROPEAN HEART JOURNAL, 2021, 42 : 859 - 859
  • [40] Prognostic impact of diagnosis of transthyretin cardiac amyloidosis
    Arana, X.
    Goena, C.
    Villanueva, I.
    Solla, I.
    Rengel, A.
    Manas, L.
    Rilo, I.
    Gomez, A.
    Querejeta, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 71 - 71